This clinical trial is focused on studying the effects of a medication called Zoledronic Acid on the healing process after surgery for a shoulder condition known as a chronic rotator cuff tear. This condition involves a tear in the tendons around the shoulder joint, which can occur due to injury or wear and tear over time. The study also considers patients with osteoporosis, a condition where bones become weak and fragile. The purpose of the study is to see if Zoledronic Acid can help improve the healing of the tendon after it has been repaired through a procedure called arthroscopic surgery, which is a minimally invasive surgery using small incisions and a camera to guide the repair.
Participants in the study will receive either Zoledronic Acid or a placebo, which is a substance with no active medication, to compare the effects. The medication will be given through an infusion, which means it is delivered directly into the bloodstream via a vein. The study will monitor the healing of the tendon using magnetic resonance imaging (MRI), a type of scan that uses magnets and radio waves to create detailed images of the inside of the body. These scans will be done at several points over a period of up to five years after the surgery to assess the integrity of the tendon and see if it has healed properly without re-tearing.
In addition to the primary focus on tendon healing, the study will also look at other factors such as muscle condition, shoulder movement, strength, and pain levels. These will be evaluated using various scores and assessments to provide a comprehensive view of the shoulder’s recovery. The study aims to provide valuable insights into whether Zoledronic Acid can be a beneficial addition to the treatment plan for individuals undergoing surgery for chronic rotator cuff tears, particularly those who also have osteoporosis.



Austria